Physician profile
Mark A Wiley
NPI 1659322899
$39,333.71
in general payments reported to CMS, 2019-2025
15 companies · $9,867 in 2025
The $9,867 reported for 2025 was more than what 89% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,570 · 2020: $867 · 2021: $9,629 · 2022: $1,853 · 2023: $11K · 2024: $3,103 · 2025: $9,867.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Food and Beverage: $6,184 · Travel and Lodging: $5,730 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,000.00 |
| Food and Beverage | $6,183.82 |
| Travel and Lodging | $5,730.11 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $27,298.14 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Evoque, Pascal |
| Medtronic, INC. | $7,061.55 | 2021-2025 | Corevalve Evolut R, Cobalt Dr Mri Surescan, Apollotm |
| Abbott Laboratories | $3,659.47 | 2019-2025 | Triclip, Mitraclip, Optis |
| E.R. Squibb & Sons, L.L.C. | $458.44 | 2024-2025 | Eliquis, Camzyos |
| Boston Scientific Corporation | $149.67 | 2022-2025 | Avvigo Guidance System, Watchman Access System |
| Abiomed | $149.61 | 2021 | |
| Medtronic Vascular, INC. | $142.67 | 2019 | |
| Philips North America LLC | $108.07 | 2024 | (Ao0) Igt Devices Intracardiac |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $93.54 | 2025 | Lifevest |
| Chiesi USA, INC. | $76.30 | 2021-2024 | Kengreal |
| Minerva Surgical, INC | $32.34 | 2022 | |
| Pfizer INC. | $31.65 | 2021-2024 | |
| Astrazeneca Pharmaceuticals Lp | $30.59 | 2022 | |
| Lantheus Medical Imaging, INC. | $28.07 | 2024-2025 | |
| Amgen INC. | $13.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Wiley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.